| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 309.00K | kr 0.00 | kr 0.00 | kr 0.00 | kr 36.19M |
| Gross Profit | kr 309.00K | kr 0.00 | kr 0.00 | kr -782.00K | kr 18.08M |
| Operating Income | kr -2.45M | kr -201.00K | kr -27.04M | kr -41.24M | kr -83.47M |
| EBITDA | kr -2.45M | kr -201.00K | kr -12.10M | kr -40.46M | kr -603.91M |
| Net Income | kr -859.00K | kr -298.00K | kr -26.05M | kr -110.59M | kr -626.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 15.93M | kr 19.97M | kr 18.21M | kr 38.92M | kr 102.25M |
| Total Assets | kr 19.54M | kr 23.56M | kr 19.31M | kr 56.83M | kr 173.23M |
| Total Debt | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 | kr 39.97M |
| Net Debt | kr -394.00K | kr -3.89M | kr -11.27M | kr -38.92M | kr -62.29M |
| Total Liabilities | kr 1.15M | kr 4.31M | kr 5.07M | kr 15.85M | kr 163.89M |
| Stockholders' Equity | kr 18.39M | kr 19.25M | kr 14.24M | kr 40.97M | kr 9.34M |
| Cash Flow | |||||
| Free Cash Flow | kr -2.14M | kr -3.36M | kr -20.02K | kr -117.94M | kr -603.57M |
| Operating Cash Flow | kr -2.14M | kr -3.36M | kr -20.02K | kr -104.52M | kr -602.57M |
| Investing Cash Flow | kr -1.36M | kr -9.33M | kr -6.94M | kr 90.35M | kr 46.00K |
| Financing Cash Flow | kr 0.00 | kr 5.31M | kr -685.00K | kr -35.08M | kr -30.34M |
Orphazyme Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.